An Internet-delivered Intervention for Coping With ADHD in Adulthood (MyADHD)
An Internet-delivered Intervention for Coping With ADHD in Adulthood - a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vestland
-
Bergen, Vestland, Norway
- Clinical Psychology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults with a self-reported diagnosis of ADHD (date, venue and diagnosing physician)
- Access to and ability to use a computer, smartphone and the Internet.
- Current problems with organizing daily activity and 17 points of more on at least one of the ASRS subscales
- Participant are by investigators considered able to follow through the training protocol and take part in measures taken during the study time frame
Speaks, writes and reads Norwegian
Exclusion Criteria:
- Current self-reported diagnosis of severe psychiatric illness such as borderline or antisocial personality disorder, bipolar disorder, ongoing substance abuse, and/or suicidal ideation assessed with item 9 on the MADRS
- Participants who are taking prescribed ADHD medication have to be stable on the medication at least four weeks before the study and during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: a self-guided Internet delivered intervention
MinADHD: 7 self-help modules.
|
The main goals of the intervention are to help participants with better functioning in daily life; offer strategies that will lead to stress reduction and reduce inattention and improve quality of life.The intervention includes: a short introductory chapter (open to everyone), followed by a start module (goal setting), followed by 6 different themed optional modules.
Module content is based on GMT, DBT and CBT techniques and is tailored towards key concerns and difficulties experienced adults with ADHD as informed by previous research (focus-groups, lived experience groups) and experiences from group GMT and DBT.
|
|
Placebo Comparator: Psycho-education
One self-guided psychoeducation module
|
Participants in the control condition will be assigned to psychoeducation modules (see Table 2) and will receive restricted access to the platform.
They can contact or be contacted if their symptoms levels increases.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Adult ADHD Self-Rating Scale (ASRS)
Time Frame: Change in ADHD symptoms at 8 weeks
|
The Adult ADHD Self-Rating Scale (ASRS) includes all the 18 symptoms of ADHD included in the diagnostic manual (DSM-5).
|
Change in ADHD symptoms at 8 weeks
|
|
Adult ADHD Quality of Life Measure (AAQol)
Time Frame: Change in quality of life at 8 weeks
|
The AAQoL has 29 items designed to assess HRQL during the past two weeks among adults with ADHD.
|
Change in quality of life at 8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The perceived stress scale (PSS)
Time Frame: Change in stress symptoms at 8 weeks
|
The Perceived Stress Scale (PSS) is a widely used psychological instrument for measuring stress.
|
Change in stress symptoms at 8 weeks
|
|
The Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Change in depression symptoms at 8 weeks
|
The Patient Health Questionnaire-9 (PHQ-9: Kroenke et al., 2001) is a self-report tool used to assess the presence and severity of depressive symptoms
|
Change in depression symptoms at 8 weeks
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence
Time Frame: immediately after the intervention
|
Usage outcomes of interest are attrition and adherence to the intervention.
|
immediately after the intervention
|
|
User satisfaction
Time Frame: immediately after the intervention
|
Four open end questions at the end of the modules:
|
immediately after the intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 203804
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.